Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H V Barron

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|March 29, 2000
Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2J G Canto, W J Rogers, W J French, et al.
Journal of the American College of Cardiology|February 17, 2000
Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial InfarctionW J Rogers, J G Canto, H V Barron, et al.
The American Journal of Cardiology|May 1, 1997
Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatmentH V Barron, H H Khan, S Viskin, et al.
Archives of Internal Medicine|March 21, 1998
Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organizationH V Barron, S Viskin, R J Lundstrom, et al.
American Heart Journal|November 14, 1997
Effect of beta-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: data from a large HMOH V Barron, S Viskin, R J Lundstrom, et al.
American Heart Journal|May 29, 2001
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2H V Barron, N R Every, L S Parsons, et al.
The American Journal of Cardiology|August 26, 1998
Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction)R J Goldberg, M Mooradd, J H Gurwitz, et al.
JAMA|January 3, 2001
Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapyD J Magid, B N Calonge, J S Rumsfeld, et al.
Circulation|December 31, 1997
Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiographyC C Wong, E S Froelicher, P Bacchetti, et al.
Circulation|April 16, 1998
Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2H V Barron, L J Bowlby, T Breen, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|March 29, 2000
Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2J G Canto, W J Rogers, W J French, et al.
Journal of the American College of Cardiology|February 17, 2000
Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial InfarctionW J Rogers, J G Canto, H V Barron, et al.
The American Journal of Cardiology|May 1, 1997
Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatmentH V Barron, H H Khan, S Viskin, et al.
Archives of Internal Medicine|March 21, 1998
Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organizationH V Barron, S Viskin, R J Lundstrom, et al.
American Heart Journal|November 14, 1997
Effect of beta-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: data from a large HMOH V Barron, S Viskin, R J Lundstrom, et al.
American Heart Journal|May 29, 2001
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2H V Barron, N R Every, L S Parsons, et al.
The American Journal of Cardiology|August 26, 1998
Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction)R J Goldberg, M Mooradd, J H Gurwitz, et al.
JAMA|January 3, 2001
Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapyD J Magid, B N Calonge, J S Rumsfeld, et al.
Circulation|December 31, 1997
Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiographyC C Wong, E S Froelicher, P Bacchetti, et al.
Circulation|April 16, 1998
Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2H V Barron, L J Bowlby, T Breen, et al.
Pageof 6